Search Results 1001-1010 of 14957 for Hepatitis C

  1. Mayo Clinic Transplant Center - Doctors

    Parag C. Patel, M.D.. Transplant Cardiologist. Jacksonville, FL. Areas of focus: Heart transplant, Pre ...

  2. Liver problems - Doctors and departments - Mayo Clinic

    Hepatitis C antibody test · Liver biopsy · Liver function tests · Liver transplant · MRI · Needle biopsy · Ultrasound. Show more associated procedures. News ...

  3. A Study Of The Safety And Efficacy Of Atezolizumab Administered In Combination With Bevacizumab And/or Other Treatments In Participants With Solid Tumors - Mayo Clinic

    ... hepatitis B core antigen (anti-HBc), and/or anti-hepatitis C virus (anti-HCV). Antiviral therapy per local standard-of-care if active hepatitis B virus (HBV).

  4. Study Of BIIB092 In Participants With Progressive Supranuclear Palsy - Mayo Clinic

    Any other sound medical, psychiatric, and/or social reason as determined by the Investigator. Current hepatitis C or hepatitis B infection. Current hepatitis C ...

  5. Primary biliary cholangitis (PBC) - Doctors and departments - Mayo Clinic

    Ilyas, M.B.B.S.. Transplant Hepatologist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, ...

  6. Nausea and vomiting In-depth - Mayo Clinic

    Hepatitis C: How common is sexual transmission? Hepatitis C: What happens in end-stage liver disease? ... How do COVID-19 antibody tests differ from diagnostic ...

  7. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States - Mayo Clinic

    Hepatitis C virus eligible for enrollment if hepatitis C virus RNA negative and after sustained virologic response at 24 weeks 2. Hepatitis B virus eligible ...

  8. Publications - Sahar Saddoughi, M.D., Ph.D. - Mayo Clinic

    Epub 2023 Apr 20. View PubMed; Saddoughi SA, Cypel M. Expanding the Lung Donor Pool: Donation After Circulatory Death, Ex-Vivo Lung Perfusion and Hepatitis C ...

  9. A Study Of Ibrutinib With Rituximab In People With Untreated Marginal Zone Lymphoma - Mayo Clinic

    (Hep C patients may be enrolled if other parameters precluding hepatic impairment are met. And they are not undergoing active therapy for hepatitis C; Human ...

  10. Belantamab, Lenalidomide, And Daratumumab For Newly-diagnosed Multiple Myeloma - Mayo Clinic

    Note: Hepatitis RNA testing is optional and participants with negative Hepatitis C antibody test are not required to also undergo Hepatitis C RNA testing.